| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Advancing data collection and analysis: 2023 revised European Network of Cancer Registries recommendations for standard dataset
|
Michalek, Irmina Maria
|
|
|
199 |
C |
p.
|
artikel
|
| 2 |
A new prognostic model in chemotherapy-treated patients with recurrent or metastatic head and neck cancer: An analysis of ECOG-ACRIN E1305
|
Argiris, Athanassios
|
|
|
199 |
C |
p.
|
artikel
|
| 3 |
Combined immunotherapy in melanoma patients with brain metastases: A multicenter international study
|
Mandalà, Mario
|
|
|
199 |
C |
p.
|
artikel
|
| 4 |
Comparing accuracy of tomosynthesis plus digital mammography or synthetic 2D mammography in breast cancer screening: baseline results of the MAITA RCT consortium
|
Giorgi Rossi, Paolo
|
|
|
199 |
C |
p.
|
artikel
|
| 5 |
Cross-trial comparisons for the adjuvant treatment of MSI colorectal cancer: dare to dream the future scenarios.
|
Pastorino, Alessandro
|
|
|
199 |
C |
p.
|
artikel
|
| 6 |
Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy in gastric cancer: A long way to go
|
Zhao, Pengyue
|
|
|
199 |
C |
p.
|
artikel
|
| 7 |
Despite multi-disciplinary team discussions the socioeconomic disparities persist in the oncological treatment of non-metastasized colorectal cancer
|
Osterman, Erik
|
|
|
199 |
C |
p.
|
artikel
|
| 8 |
Early morning immune checkpoint blockade and overall survival of patients with metastatic cancer: An In-depth chronotherapeutic study
|
Catozzi, Simona
|
|
|
199 |
C |
p.
|
artikel
|
| 9 |
Editorial Board
|
|
|
|
199 |
C |
p.
|
artikel
|
| 10 |
Effect of Concomitant Medications on Treatment Response and Survival in De Novo Metastatic Prostate Cancer: Secondary Analysis of the LATITUDE Study
|
Roy, Soumyajit
|
|
|
199 |
C |
p.
|
artikel
|
| 11 |
Effect of high-field iMRI guided resection in cerebral glioma surgery: A randomized clinical trial
|
Li, Zeyang
|
|
|
199 |
C |
p.
|
artikel
|
| 12 |
Efficacy and safety of ‘Second Adjuvant’ therapy with BRAF/MEK inhibitors after local therapy for recurrent melanoma following adjuvant PD-1 based immunotherapy
|
Taylor, Amelia M.
|
|
|
199 |
C |
p.
|
artikel
|
| 13 |
Efficacy of immune checkpoint inhibitors for metastatic colorectal cancer with microsatellite instability in second or latter line using synthetic control arms: A non-randomised evaluation
|
Cohen, Romain
|
|
|
199 |
C |
p.
|
artikel
|
| 14 |
First-line immunotherapy for lung cancer with MET exon 14 skipping and the relevance of TP53 mutations
|
Blasi, Miriam
|
|
|
199 |
C |
p.
|
artikel
|
| 15 |
Gastrointestinal metastases in renal cell carcinoma: A retrospective multicenter GETUG (Groupe d′Étude des Tumeurs Uro-Génitales) study
|
Carneiro, F.
|
|
|
199 |
C |
p.
|
artikel
|
| 16 |
Incidence, clinical management and prognosis of patients with small intestinal adenocarcinomas from 1999 through 2019: A nationwide Dutch cohort study
|
de Back, Tim R.
|
|
|
199 |
C |
p.
|
artikel
|
| 17 |
Letter re: Hyperprogression in advanced melanoma is not restricted to immunotherapy
|
Yang, Fan
|
|
|
199 |
C |
p.
|
artikel
|
| 18 |
Long-term patient-reported outcomes from monarchE: Abemaciclib plus endocrine therapy as adjuvant therapy for HR+, HER2-, node-positive, high-risk, early breast cancer
|
Tolaney, Sara M.
|
|
|
199 |
C |
p.
|
artikel
|
| 19 |
Nivolumab plus ipilimumab in melanoma patients with asymptomatic brain metastases: 7-year outcomes and quality of life from the multicenter phase III NIBIT-M2 trial
|
Di Giacomo, Anna Maria
|
|
|
199 |
C |
p.
|
artikel
|
| 20 |
Outcomes of patients with resected stage III/IV acral or mucosal melanoma, treated with adjuvant anti-PD-1 based therapy
|
Jacques, Sarah K.
|
|
|
199 |
C |
p.
|
artikel
|
| 21 |
Prediction of prognosis and treatment response in ovarian cancer patients from histopathology images using graph deep learning: a multicenter retrospective study
|
Yang, Zijian
|
|
|
199 |
C |
p.
|
artikel
|
| 22 |
Revolutionizing anti-HER2 therapies for extrahepatic cholangiocarcinoma and gallbladder cancer: Current advancements and future perspectives
|
ten Haaft, Britte H.E.A
|
|
|
199 |
C |
p.
|
artikel
|
| 23 |
Safety profile of pembrolizumab monotherapy based on an aggregate safety evaluation of 8937 patients
|
Brahmer, Julie R.
|
|
|
199 |
C |
p.
|
artikel
|
| 24 |
Shrinking sample sizes in lung cancer trials: Various explanations, open questions
|
Olivier, Timothée
|
|
|
199 |
C |
p.
|
artikel
|
| 25 |
Surufatinib plus toripalimab in patients with advanced neuroendocrine tumours and neuroendocrine carcinomas: An open-label, single-arm, multi-cohort phase II trial
|
Zhang, Panpan
|
|
|
199 |
C |
p.
|
artikel
|
| 26 |
The side effect registry immuno-oncology (SERIO) – A tool for systematic analysis of immunotherapy-induced side effects
|
Ertl, Carolin
|
|
|
199 |
C |
p.
|
artikel
|
| 27 |
Tumor-positive peritoneal cytology in patients with gastric cancer is associated with poor outcome: A nationwide study
|
Van Der Sluis, Karen
|
|
|
199 |
C |
p.
|
artikel
|
Tijdschrift beschrijving